Kinoxis Therapeutics Pty Ltd

Biotechnology - , Victoria, Australia

Kinoxis Therapeutics Pty Ltd Employees
Sharon Hanegraaf

Vice President, Drug Development

Contact Sharon Hanegraaf

Raymond Luong

Drug Development Associate

Contact Raymond Luong

Hugh Alsop

Chief Executive Officer

Contact Hugh Alsop

Contact All Kinoxis Therapeutics Pty Ltd Employees
Kinoxis Therapeutics Pty Ltd Senior Management
Hugh Alsop

Chief Executive Officer

Contact Hugh Alsop

Contact All Kinoxis Therapeutics Pty Ltd Employees
Kinoxis Therapeutics Pty Ltd Details

Kinoxis Therapeutics is a private, Australian-based, late preclinical stage biotechnology company developing first-in-class therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders. Kinoxis' development candidates are novel, small molecules that were discovered through a comprehensive medicinal chemistry and screening program at the University of Sydney. Kinoxis is backed by Uniseed, Australia's longest running venture fund, and a consortium of sophisticated investors, and secured funding from the US National Institutes of Health National Institute on Drug Abuse for the development of its lead compound to mitigate opioid withdrawal symptoms.Kinoxis' lead candidate (KNX100) is being developed for the mitigation of opioid withdrawal symptoms. KNX100 has a novel, undisclosed mechanism of action and is nearing Phase I clinical trials. The company is also exploring other indications for KNX100, as promising preclinical results have been achieved in animal models of cocaine, methamphetamine, nicotine, and alcohol use disorders, as well as models of agitation and aggression.Kinoxis' second series of compounds target the oxytocin receptor, through either selective partial agonism or positive allosteric modulation. The brain oxytocin system has been identified as perhaps the most important molecular target for regulating social behaviour and is therefore a major target of interest for treating a wide range of mental disorders. The development of these compounds will be focused on treating conditions that feature social dysfunction as a core symptom, such as neurodevelopmental disorders (including autism spectrum disorder) social anxiety disorder, dementia (including Alzheimer's disease), and schizophrenia.

Kinoxis Therapeutics Pty Ltd logo, Kinoxis Therapeutics Pty Ltd contact details
Employees: 1 - 10
HQ:
Location: , Victoria, Australia
Revenue:
Kinoxis Therapeutics Pty Ltd Technologies
Email Providers

Outlook

CMS

WordPress.org

Fonts

Google Font API

Tag Management

Google Tag Manager

Other

Mobile Friendly

View All Technologies Used At Kinoxis Therapeutics Pty Ltd

Contacting Kinoxis Therapeutics Pty Ltd: Connect with Executives and Employees

Get in Touch with Kinoxis Therapeutics Pty Ltd Executives and Employees

Connecting with Kinoxis Therapeutics Pty Ltd's Executives and Workforce

Accessing Contact Information for Kinoxis Therapeutics Pty Ltd Executives

Connecting with Kinoxis Therapeutics Pty Ltd: Reach Out to Their Team

Discover How to Contact Kinoxis Therapeutics Pty Ltd Executives and Staff

Looking to connect with Kinoxis Therapeutics Pty Ltd executives or employees?

Seeking to Get in Touch with Kinoxis Therapeutics Pty Ltd Executives or Staff?

Want to Reach Out to Kinoxis Therapeutics Pty Ltd Executives or Team Members?

In Search of Contact Details for Kinoxis Therapeutics Pty Ltd Professionals?

Connecting with Kinoxis Therapeutics Pty Ltd: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z